QTc interval prolongation predicts the ablation outcome in hypertensive patients with paroxysmal atrial fibrillation
QTc interval prolongation predicts the ablation outcome in hypertensive patients with paroxysmal atrial fibrillation
复制标题
QTc 间期延长可预测高血压合并阵发性房颤患者的消融结果
DOI:
10.1093/eurheartj/suv017
复制
发表时间:
2015
影响因子:
1.6
通讯作者:
Ma Chang-Sheng
中科院分区:
文献类型:
--
作者:
Liu Nian;Wen Song-Nan;Ruan Yan-Fei;Zhang Ting;Li Song-Nan;Wu Jia-Hui;Jiang Chen-Xi;Tang Ri-Bo;Long De-Yong;Bai Rong;Yu Rong-Hui;Du Xin;Dong Jian-Zheng;Ma Chang-Sheng
An abnormal corrected QT (QTc) interval is associated with the development of atrial fibrillation (AF). It is unclear whether QTc interval is a marker of arrhythmia recurrence after radiofrequency catheter ablation (RFCA) in patients with AF. This study sought to determine the relationship between abnormal QTc interval and the recurrence after RFCA in hypertensive patients with paroxysmal AF. Two hundred and forty-two hypertensive patients with paroxysmal AF who underwent first time RFCA were retrospectively evaluated. Baseline data and QTc before the procedure were collected. Ninety-eight patients had AF recurrence after a mean follow-up of 17.0 ± 9.4 months. Those experiencing recurrence had a longer QTc interval than those without recurrence (429 ± 26 vs. 419 ± 23 ms, P = 0.004). Multivariate Cox regression analysis demonstrated the QTc interval and left atrial diameter (LAD) as independent predictors of AF recurrence. Patients with a long QTc interval were at an increased risk of AF recurrence (hazard ratio 2.757, 95% CI 1.661–4.611, P < 0.001) after adjustment for multiple factors. The QTc interval had an incremental value combined with the LAD in predicting AF recurrence after RFCA. The patients with a large LAD and a long QTc interval had a much higher AF recurrence rate compared with those with a small LAD and a non-long QTc interval (78 vs. 27%, P < 0.001). QTc interval prolongation is an independent risk factor for AF recurrence after RFCA in hypertensive patients. It provides a simple predictor for identifying the patients with hypertension likely to have AF recurrence after RFCA.